Copyright Reports & Markets. All rights reserved.

Global EGFR-TKI for Advanced NSCLC Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global EGFR-TKI for Advanced NSCLC Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 Gefitinib
    • 1.2.3 Erlotinib
    • 1.2.4 Afatinib
  • 1.3 Market by Application
    • 1.3.1 Global EGFR-TKI for Advanced NSCLC Market Share by Application: 2020 VS 2026
    • 1.3.2 Combination Therapy
    • 1.3.3 Mono Therapy
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global EGFR-TKI for Advanced NSCLC Market Perspective (2015-2026)
  • 2.2 Global EGFR-TKI for Advanced NSCLC Growth Trends by Regions
    • 2.2.1 EGFR-TKI for Advanced NSCLC Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 EGFR-TKI for Advanced NSCLC Historic Market Share by Regions (2015-2020)
    • 2.2.3 EGFR-TKI for Advanced NSCLC Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top EGFR-TKI for Advanced NSCLC Players by Market Size
    • 3.1.1 Global Top EGFR-TKI for Advanced NSCLC Players by Revenue (2015-2020)
    • 3.1.2 Global EGFR-TKI for Advanced NSCLC Revenue Market Share by Players (2015-2020)
  • 3.2 Global EGFR-TKI for Advanced NSCLC Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by EGFR-TKI for Advanced NSCLC Revenue
  • 3.4 Global EGFR-TKI for Advanced NSCLC Market Concentration Ratio
    • 3.4.1 Global EGFR-TKI for Advanced NSCLC Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by EGFR-TKI for Advanced NSCLC Revenue in 2019
  • 3.5 Key Players EGFR-TKI for Advanced NSCLC Area Served
  • 3.6 Key Players EGFR-TKI for Advanced NSCLC Product Solution and Service
  • 3.7 Date of Enter into EGFR-TKI for Advanced NSCLC Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 EGFR-TKI for Advanced NSCLC Breakdown Data by Type (2015-2026)

  • 4.1 Global EGFR-TKI for Advanced NSCLC Historic Market Size by Type (2015-2020)
  • 4.2 Global EGFR-TKI for Advanced NSCLC Forecasted Market Size by Type (2021-2026)

5 EGFR-TKI for Advanced NSCLC Breakdown Data by Application (2015-2026)

  • 5.1 Global EGFR-TKI for Advanced NSCLC Historic Market Size by Application (2015-2020)
  • 5.2 Global EGFR-TKI for Advanced NSCLC Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America EGFR-TKI for Advanced NSCLC Market Size (2015-2026)
  • 6.2 North America EGFR-TKI for Advanced NSCLC Market Size by Type (2015-2020)
  • 6.3 North America EGFR-TKI for Advanced NSCLC Market Size by Application (2015-2020)
  • 6.4 North America EGFR-TKI for Advanced NSCLC Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe EGFR-TKI for Advanced NSCLC Market Size (2015-2026)
  • 7.2 Europe EGFR-TKI for Advanced NSCLC Market Size by Type (2015-2020)
  • 7.3 Europe EGFR-TKI for Advanced NSCLC Market Size by Application (2015-2020)
  • 7.4 Europe EGFR-TKI for Advanced NSCLC Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China EGFR-TKI for Advanced NSCLC Market Size (2015-2026)
  • 8.2 China EGFR-TKI for Advanced NSCLC Market Size by Type (2015-2020)
  • 8.3 China EGFR-TKI for Advanced NSCLC Market Size by Application (2015-2020)
  • 8.4 China EGFR-TKI for Advanced NSCLC Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 Japan

  • 9.1 Japan EGFR-TKI for Advanced NSCLC Market Size (2015-2026)
  • 9.2 Japan EGFR-TKI for Advanced NSCLC Market Size by Type (2015-2020)
  • 9.3 Japan EGFR-TKI for Advanced NSCLC Market Size by Application (2015-2020)
  • 9.4 Japan EGFR-TKI for Advanced NSCLC Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Southeast Asia

  • 10.1 Southeast Asia EGFR-TKI for Advanced NSCLC Market Size (2015-2026)
  • 10.2 Southeast Asia EGFR-TKI for Advanced NSCLC Market Size by Type (2015-2020)
  • 10.3 Southeast Asia EGFR-TKI for Advanced NSCLC Market Size by Application (2015-2020)
  • 10.4 Southeast Asia EGFR-TKI for Advanced NSCLC Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE
    • 10.4.4 Rest of Middle East & Africa

11Key Players Profiles

  • 11.1 Henan DaKen Chemical
    • 11.1.1 Henan DaKen Chemical Company Details
    • 11.1.2 Henan DaKen Chemical Business Overview
    • 11.1.3 Henan DaKen Chemical EGFR-TKI for Advanced NSCLC Introduction
    • 11.1.4 Henan DaKen Chemical Revenue in EGFR-TKI for Advanced NSCLC Business (2015-2020))
    • 11.1.5 Henan DaKen Chemical Recent Development
  • 11.2 Capot Chemical Co.,Ltd.
    • 11.2.1 Capot Chemical Co.,Ltd. Company Details
    • 11.2.2 Capot Chemical Co.,Ltd. Business Overview
    • 11.2.3 Capot Chemical Co.,Ltd. EGFR-TKI for Advanced NSCLC Introduction
    • 11.2.4 Capot Chemical Co.,Ltd. Revenue in EGFR-TKI for Advanced NSCLC Business (2015-2020)
    • 11.2.5 Capot Chemical Co.,Ltd. Recent Development
  • 11.3 Chemwill Asia Co.,Ltd.
    • 11.3.1 Chemwill Asia Co.,Ltd. Company Details
    • 11.3.2 Chemwill Asia Co.,Ltd. Business Overview
    • 11.3.3 Chemwill Asia Co.,Ltd. EGFR-TKI for Advanced NSCLC Introduction
    • 11.3.4 Chemwill Asia Co.,Ltd. Revenue in EGFR-TKI for Advanced NSCLC Business (2015-2020)
    • 11.3.5 Chemwill Asia Co.,Ltd. Recent Development
  • 11.4 MSN Labs
    • 11.4.1 MSN Labs Company Details
    • 11.4.2 MSN Labs Business Overview
    • 11.4.3 MSN Labs EGFR-TKI for Advanced NSCLC Introduction
    • 11.4.4 MSN Labs Revenue in EGFR-TKI for Advanced NSCLC Business (2015-2020)
    • 11.4.5 MSN Labs Recent Development
  • 11.5 Sun Pharma
    • 11.5.1 Sun Pharma Company Details
    • 11.5.2 Sun Pharma Business Overview
    • 11.5.3 Sun Pharma EGFR-TKI for Advanced NSCLC Introduction
    • 11.5.4 Sun Pharma Revenue in EGFR-TKI for Advanced NSCLC Business (2015-2020)
    • 11.5.5 Sun Pharma Recent Development
  • 11.6 Amadis Chemical
    • 11.6.1 Amadis Chemical Company Details
    • 11.6.2 Amadis Chemical Business Overview
    • 11.6.3 Amadis Chemical EGFR-TKI for Advanced NSCLC Introduction
    • 11.6.4 Amadis Chemical Revenue in EGFR-TKI for Advanced NSCLC Business (2015-2020)
    • 11.6.5 Amadis Chemical Recent Development
  • 11.7 Chongqing Chemdad Co., Ltd
    • 11.7.1 Chongqing Chemdad Co., Ltd Company Details
    • 11.7.2 Chongqing Chemdad Co., Ltd Business Overview
    • 11.7.3 Chongqing Chemdad Co., Ltd EGFR-TKI for Advanced NSCLC Introduction
    • 11.7.4 Chongqing Chemdad Co., Ltd Revenue in EGFR-TKI for Advanced NSCLC Business (2015-2020)
    • 11.7.5 Chongqing Chemdad Co., Ltd Recent Development
  • 11.8 Mylan
    • 11.8.1 Mylan Company Details
    • 11.8.2 Mylan Business Overview
    • 11.8.3 Mylan EGFR-TKI for Advanced NSCLC Introduction
    • 11.8.4 Mylan Revenue in EGFR-TKI for Advanced NSCLC Business (2015-2020)
    • 11.8.5 Mylan Recent Development
  • 11.9 Alchem Pharmtech,Inc.
    • 11.9.1 Alchem Pharmtech,Inc. Company Details
    • 11.9.2 Alchem Pharmtech,Inc. Business Overview
    • 11.9.3 Alchem Pharmtech,Inc. EGFR-TKI for Advanced NSCLC Introduction
    • 11.9.4 Alchem Pharmtech,Inc. Revenue in EGFR-TKI for Advanced NSCLC Business (2015-2020)
    • 11.9.5 Alchem Pharmtech,Inc. Recent Development

12Analyst's Viewpoints/Conclusions

    13Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    EGFR-TKI for Advanced NSCLC market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global EGFR-TKI for Advanced NSCLC market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    Gefitinib
    Erlotinib
    Afatinib

    Market segment by Application, split into
    Combination Therapy
    Mono Therapy

    Based on regional and country-level analysis, the EGFR-TKI for Advanced NSCLC market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa

    In the competitive analysis section of the report, leading as well as prominent players of the global EGFR-TKI for Advanced NSCLC market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    Henan DaKen Chemical
    Capot Chemical Co.,Ltd.
    Chemwill Asia Co.,Ltd.
    MSN Labs
    Sun Pharma
    Amadis Chemical
    Chongqing Chemdad Co., Ltd
    Mylan
    Buy now